Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win fkansteiner Mon, 02/28/2022 – 10:52
Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refiling esagonowsky Mon, 02/28/2022 – 10:34
Bristol Myers’ Opdivo steps in FDA fast lane for potential first-in-class nod in pre-surgery lung cancer aliu Mon, […]
After raking in billions with its COVID shot, Moderna faces patent infringement suit related to vaccine delivery tech […]
‘Light up for Rare’ spotlights rare disease to help break the isolation COVID has wrought badams Mon, 02/28/2022 […]
Extract from the bark of the Neem tree may help treat and reduce the spread of coronavirus, according […]
Using computer drug simulations, researchers have found that doctors need to be wary of prescribing a promising treatment […]
Scientists at Charité – Universitätsmedizin Berlin have collected data from 1,647 preeclampsia patients and used machine learning methods […]
